Artículos de revistas
A Clinical, Epidemiological, Laboratorial, Histological And Ultrasonographical Evaluation Of Anti-hcv Eia-2 Positive Blood Donors
Registro en:
Revista Do Instituto De Medicina Tropical De Sao Paulo. , v. 42, n. 3, p. 147 - 152, 2000.
364665
2-s2.0-3142518315
Autor
Goncales Jr. F.L.
Stucchi R.S.B.
Pavan M.H.P.
Escanhoela C.A.F.
Yamanaka A.
Magna L.A.
Goncales N.S.L.
Institución
Resumen
Between 1992 and 1997, 790 blood donors with anti-HCV EIA-2 strongly reagent (relationship between the sample optical density/cut-off > 3) detected at the blood bank serological screening, were evaluated in ambulatory environment. They were all negative for Chagas disease, syphilis, hepatitis B (HBsAg) and AIDS. Blood samples were collected at the first ambulatorial evaluation, for hemogram, biochemical tests and new serological tests for HCV (anti-HCV EIA-2). In blood samples of 226 repeatedly reagent anti-HCV EIA-2 blood donors, supplementary "immunoblot" test for HCV (RIBA-2) was used. In 209 donors, the presence of HCV-RNA was investigated by the PCR test. The abdominal ultrasonography was realized in 366 donors. In 269 patients liver biopsy was performed for the histopathological study. The follow-up of blood donors showed that 95.6% were repeatedly EIA-2 reagent, 94% were symptomless and denied any hepatitis history, with only 2% mentioning previous jaundice. In 47% of this population at least one risk factor has been detected for the HCV transmission, the use of intravenous drugs being the main one (27.8%). Blood transfusion was the second factor for HCV transmission (27.2%). Hepatomegaly was detected in 54% of the cases. Splenomegaly and signs of portal hypertension have seldom been found in the physical examination, indicating a low degree of hepatic compromising in HCV. Abdominal ultrasound showed alterations in 65% of the subjects, being the steatosis the most frequent (50%). In 83.5% of the donors submitted to the liver biopsy, the histopathological exam showed the presence of chronic hepatitis, usually classified as active (89%) with mild or moderate grade in most of the cases (99.5%). The histopathological exam of the liver was normal in 1.5% of blood donors. The RIBA-2 test and the HCV-RNA investigation by PCR were positive in respectively 91.6 and 75% of the anti-HCV EIA-2 reagent donors. The HCV-RNA research was positive in 82% of the RIBA-2 positive subjects, in 37.5% of the indeterminate RIBA-2 donors and in 9% of the negative RIBA-2 donors. Chronic hepatitis has also been observed in 50% of the histopathologieal exams of the anti-HCV EIA-2 reagent donors which were, indeterminate RIBA-2. Among 18 blood donors with minimal changes histopathological exam 11 (61%) were HCV-RNA positive. Our blood donors anti-HCV reagent generally had clinical, laboratorial and histopathological features observed in patients with chronic HCV hepatitis and a high proportion could be identified in interviews and medical evaluation realized in blood blanks. Generally, these HCV infected donors are identified and discharged only by the serological tests results. 42 3 147 152 Alter, H.J., To C or not to C: These are the questions (1995) Blood, 85, pp. 1631-1695 Alter, H.J., Conry-Cantilena, C., Melpolder, J., Hepatitis C in asymptomatic blood donors (1997) Hepatology, 26 (1 SUPPL.), pp. 29S-33S Alter, H.J., Purcell, R.H., Shih, J.W., Detection of antibodies to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis (1989) New Engl. J. Med., 321, pp. 1494-1500 Alter, H.J., Tegtmeier, G., Jett, B., The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors (1991) Transfusion, 31, pp. 771-776 Alter, M.J., Epidemiology of hepatitis C in the West (1995) Semin. Liver Dis., 15, pp. 5-14 Areias, J., Pedroto, I., Freitas, T., Hepatitis C virus carriers with normal ALT activity: Viraemia, genotype and effect of interferon therapy (1996) Gastroenterology, 110, pp. A1143 Choo, Q.L., Kuo, G., Weiner, A.J., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome (1989) Science, 244, pp. 359-362 Conry-Cantilena, C., Van Raden, M., Gibble, J., Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C infection (1996) New Engl. J. Med., 334, pp. 1691-1696 Esteban, J.I., Esteban, R., Viladomiu, L., Hepatitis C virus antibodies among risk groups in Spain (1989) Lancet, 2, pp. 294-297 Esteban, J.I., Gonzales, A., Hernandez, J.M., Evaluation of antibodies to hepatitis C virus in a contemporary study of transfusion-associated hepatitis (1990) New Engl. J. Med., 323, pp. 1107-1112 Garcia-Samaniego, J., Enriquez, A., Soriano, V., Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples (1993) Vox Sang., 64, pp. 191-192. , Basel Hoofnagle, J.H., Hepatitis C: The clinical spectrum of disease (1997) Hepatology, 26 (1 SUPPL.), pp. 15S-20S Kleinman, S., Alter, H., Busch, M., Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay (1992) Transfusion, 32, pp. 805-813 Kuo, G., Choo, Q.L., Alter, H.J., An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis (1989) Science, 244, pp. 362-364 Lok, A.S.F., Gunaratnam, N.T., Diagnosis of hepatitis C (1997) Hepatology, 26 (1 SUPPL.), pp. 48S-56S Prati, D., Capelli, C., Zanella, A., Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection (1996) Gastroenterology, 100, pp. 178-183 Prieto, M., Olaso, V., Verdu, C., Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction (1995) Hepatology, 22, pp. 413-417 Prince, A.M., Brotman, B., Inchauspe, G., Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis (1993) J. Infect.Dis, 167, pp. 1296-1301 Rossini, A., Gazzola, G.B., Ravaggi, A., Long-term follow-up and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels (1995) Transfusion, 35, pp. 108-111 Salmeron, F.J., Palacios, A., Perez-Ruiz, M., Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2 positive blood donors (1996) Dig. Dis. Sci., 41, pp. 1933-1938 Schiff, E.R., Hepatitis C and alcohol (1997) Hepatology, 26 (1 SUPPL.), pp. 39S-42S Serfaty, L., Nousbaum, J.R., Elghouzzi, M.H., Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test (1995) Hepatology, 21, pp. 725-729 Shakil, A.O., Conry-Cantilena, C., Alter, H.J., Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic and histologic features (1995) Ann. Intern. Med., 123, pp. 330-337 Sharara, A.I., Hunt, C.M., Hamilton, J.D., Hepatitis C (1996) Ann. Intern. Med., 125, pp. 658-668 Ulrich, P., Romeo, J., Lane, P., Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase (1990) J. Clin. Invest., 86, pp. 1609-1614